Neurostatus Systems AG
We are pleased to inform you that by beginning of August 2016 we have transferred all Neurostatus
activities to the Neurologic Clinic and Policlinic of the University Hospital Basel.
We would like to thank you for your continuous support and trust throughout the last 20 years.
For more information on this transition please download the Communiqué below.

News

Press release – Transfer of Ownership of Neurostatus Services and Tools to University Hospital Basel

Publication in Multiple Sclerosis Journal

Neurostatus e-Scoring increases EDSS consistency up to 99.7%

All News

Job offers

There are no open jobs at the moment.

Neurostatus Systems AG
Close

Neurostatus
News

Neurostatus e-Scoring increases EDSS consistency up to 99.7%

Neurostatus e-Scoring increases EDSS consistency up to 99.7% compared to the paper assessment method (82%).

Read more in this article published on LinkedIn and attend the oral presentation of Neurostatus e-Scoring system performance results at ECTRIMS 2015:

"Neurostatus e-Scoring (NESC): first experience in a phase 3 clinical trial with siponimod (BAF312) in secondary progressive multiple sclerosis (EXPAND)"
M.D'Souza et al.

Session Title: Parallel Session 2 - New challenges in clinical trial design
Session Date: Thursday, 8 October 2015
Presenting Time: 11:49 - 12:01